Drug search by name

Fenofibric Acid Delayed Release Capsules and Biliary cirrhosis

Result of checking the interaction of drug Fenofibric Acid Delayed Release Capsules and disease Biliary cirrhosis for safety when used together.

Check result:

Fenofibric Acid Delayed Release Capsules <> Biliary cirrhosis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of fibric acid derivatives is contraindicated in patients with primary biliary cirrhosis. These agents may further raise the already elevated cholesterol in these patients.

References:

"Product Information. Tricor (fenofibrate)." Abbott Pharmaceutical, Abbott Park, IL.
"Product Information. Atromid-S (clofibrate)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
"Product Information. Lopid (gemfibrozil)." Parke-Davis, Morris Plains, NJ.

Fenofibric Acid Delayed Release Capsules

Generic Name: fenofibric acid

Brand Name: Fibricor, Trilipix

Synonyms: Fenofibric acid, Fenofibric Acid

What is Fenofibric Acid Delayed Release Capsules?